RECORD // Company

Beta Bionics, Inc.

Formerly: Beta Bionics, Inc

Built 2026-11-22T00:09:28Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (1 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

SEC EDGAR (1)
Matched by name only, not merged (7)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • BETA BIONICS, INC. · Ct business · same registered legal name as 'Beta Bionics, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • Beta Bionics, Inc. · Ct business · same registered legal name as 'Beta Bionics, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • Beta Bionics, Inc. · Ctgov · same registered legal name as 'Beta Bionics, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • BETA BIONICS · East licences · exact name match to 'Beta Bionics, Inc.' (no other entity shares the name) Possible match based on name, not a shared identifier. Compare the records. Compare
  • BETA BIONICS, INC · East licences · same registered legal name as 'Beta Bionics, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • BETA BIONICS, INC. · Ny corps · same registered legal name as 'Beta Bionics, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • BETA BIONICS, INC. · USAspending · same registered legal name as 'Beta Bionics, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare

3 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-10-27 · accession 0001674632-26-000003

ItemValuePeriodFormFiledAccessionReport
Revenue$35,505,0003 months ended 2026-09-3010-Q2026-10-270001674632-26-0000032026-11-22 00:09 UTCReport an error
Net income (loss)$-24,353,0003 months ended 2026-09-3010-Q2026-10-270001674632-26-0000032026-11-22 00:09 UTCReport an error
Cash and cash equivalents$81,551,000at 2026-09-3010-Q2026-10-270001674632-26-0000032026-11-22 00:09 UTCReport an error

Negative as reported in the filing.

Not in this report's XBRL: Interest expense.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001674632
Ticker
BBNX
EIN
475386878
CUSIP
08659B102
Record ID
sx:sec:0001674632

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

34 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-18SEC EDGAR company profile2026-11-22 00:09 UTCReport an error
SIC industry3841 Surgical & Medical Instruments & Apparatus2026-11-18SEC EDGAR company profile2026-11-22 00:09 UTCReport an error
State of incorporationDE2026-11-18SEC EDGAR company profile2026-11-22 00:09 UTCReport an error
Fiscal year end (MMDD)12312026-11-18SEC EDGAR company profile2026-11-22 00:09 UTCReport an error
Business address11 HUGHES, IRVINE, CA, 926182026-11-18SEC EDGAR company profile2026-11-22 00:09 UTCReport an error
ExchangesNasdaq2026-11-18SEC EDGAR company profile2026-11-22 00:09 UTCReport an error
Revenue (fiscal year ended 2025-12-31)$100,251,0002025-12-3110-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax2026-11-22 00:09 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$-73,200,0002025-12-3110-K, XBRL NetIncomeLoss2026-11-22 00:09 UTCReport an error
Total assets (at 2025-12-31)$328,743,0002025-12-3110-K, XBRL Assets2026-11-22 00:09 UTCReport an error
Stockholders' equity (at 2025-12-31)$287,610,0002025-12-3110-K, XBRL StockholdersEquity2026-11-22 00:09 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$31,576,0002025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-22 00:09 UTCReport an error
Operating cash flow (fiscal year ended 2025-12-31)$-50,925,0002025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-22 00:09 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31)$5,297,0002025-12-3110-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment2026-11-22 00:09 UTCReport an error
Remaining performance obligation (at 2025-12-31)$1,600,0002025-12-3110-K, XBRL RevenueRemainingPerformanceObligation2026-11-22 00:09 UTCReport an error
Operating lease liabilities (at 2025-12-31)$7,303,0002025-12-3110-K, XBRL OperatingLeaseLiability2026-11-22 00:09 UTCReport an error
Form D total offering amount (D filed 2023-09-15)$101,784,7252023-09-15D2026-11-22 00:09 UTCReport an error
Form D total amount sold (D filed 2023-09-15)$99,499,9822023-09-15D2026-11-22 00:09 UTCReport an error
Form D industry groupOther Health Care2023-09-15D2026-11-22 00:09 UTCReport an error
Form D revenue rangeDecline to Disclose2023-09-15D2026-11-22 00:09 UTCReport an error
Form D date of first sale2023-08-282023-09-15D2026-11-22 00:09 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-10-27)On October 27, 2026, Beta Bionics, Inc. (the “Company”) issued a press release announcing its financial results for the third quarter ended September 30, 2026. A copy of the press release is attached hereto as Exhibit 99.1. The information contained under this Item 2.02, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or under the Exchange Act, regardless of any general incorporation language in any such filing…2026-10-27SEC EDGAR 8-K 0001171843-26-006856 (text as filed, excerpt)2026-11-22 00:09 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-07-29)On July 29, 2026, Beta Bionics, Inc. (the “Company”) issued a press release announcing its financial results for the second quarter ended June 30, 2026. A copy of the press release is attached hereto as Exhibit 99.1. The information contained under this Item 2.02, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or under the Exchange Act, regardless of any general incorporation language in any such filing, unless…2026-07-29SEC EDGAR 8-K 0001171843-26-005010 (text as filed, excerpt)2026-11-22 00:09 UTCReport an error
Plan (pension, plan no. 001)BETA BIONICS 401(K) PLAN: 477 participants, assets $24,903,6382025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-22 00:09 UTCReport an error
Plan (welfare, plan no. 501)BETA BIONICS, INC. HEALTH AND WELFARE PLAN: 433 participants2025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-22 00:09 UTCReport an error
Largest institutional holder #1 (13F as filed): EVENTIDE ASSET MANAGEMENT, LLC$98,053,9512026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:09 UTCReport an error
Largest institutional holder #2 (13F as filed): Soleus Capital Management, L.P.$68,849,4982026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:09 UTCReport an error
Largest institutional holder #3 (13F as filed): Sands Capital Alternatives, LLC$58,105,0342026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:09 UTCReport an error
Largest institutional holder #4 (13F as filed): BlackRock, Inc.$52,340,4792026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:09 UTCReport an error
Largest institutional holder #5 (13F as filed): Point72 Asset Management, L.P.$35,330,8832026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:09 UTCReport an error
Largest institutional holder #6 (13F as filed): VANGUARD CAPITAL MANAGEMENT LLC$27,929,3622026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:09 UTCReport an error
Largest institutional holder #7 (13F as filed): Vestal Point Capital, LP$25,072,0002026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:09 UTCReport an error
Largest institutional holder #8 (13F as filed): RTW INVESTMENTS, LP$23,505,0002026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:09 UTCReport an error
Largest institutional holder #9 (13F as filed): DEERFIELD MANAGEMENT COMPANY, L.P.$20,747,0802026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:09 UTCReport an error
Largest institutional holder #10 (13F as filed): Omega Fund Management, LLC$20,624,5882026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:09 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.